These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27102208)

  • 21. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
    Dougall WC; Kurtulus S; Smyth MJ; Anderson AC
    Immunol Rev; 2017 Mar; 276(1):112-120. PubMed ID: 28258695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering anticancer T cells for extended functional longevity.
    Pawelec G; Mariani E; McLeod J; Ben-Yehuda A; Fulop T; Aringer M; Barnett Y
    Ann N Y Acad Sci; 2004 Jun; 1019():178-85. PubMed ID: 15247010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
    Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
    Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint protein inhibition for cancer: preclinical justification for CTLA-4 and PD-1 blockade and new combinations.
    Baksh K; Weber J
    Semin Oncol; 2015 Jun; 42(3):363-77. PubMed ID: 25965355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
    Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
    PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere shortening and immune activity in war veterans with posttraumatic stress disorder.
    Jergović M; Tomičević M; Vidović A; Bendelja K; Savić A; Vojvoda V; Rac D; Lovrić-Čavar D; Rabatić S; Jovanovic T; Sabioncello A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():275-83. PubMed ID: 24977331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
    Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
    PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls.
    Tavenier J; Langkilde A; Haupt TH; Henriksen JH; Jensen FK; Petersen J; Andersen O
    BMC Immunol; 2015 Nov; 16():72. PubMed ID: 26611787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
    Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
    Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas.
    Wang Y; Wu L; Tian C; Zhang Y
    Ann Hematol; 2018 Feb; 97(2):229-237. PubMed ID: 29128997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8
    Okoye IS; Houghton M; Tyrrell L; Barakat K; Elahi S
    Front Immunol; 2017; 8():1215. PubMed ID: 29033936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic alcohol increases CD8+ T-cell immunosenescence in simian immunodeficiency virus-infected rhesus macaques.
    Katz PS; Siggins RW; Porretta C; Armstrong ML; Zea AH; Mercante DE; Parsons C; Veazey RS; Bagby GJ; Nelson S; Molina PE; Welsh DA
    Alcohol; 2015 Dec; 49(8):759-65. PubMed ID: 26603633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
    Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
    Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T Cell Immunosenescence after Early Life Adversity: Association with Cytomegalovirus Infection.
    Elwenspoek MMC; Sias K; Hengesch X; Schaan VK; Leenen FAD; Adams P; Mériaux SB; Schmitz S; Bonnemberger F; Ewen A; Schächinger H; Vögele C; Muller CP; Turner JD
    Front Immunol; 2017; 8():1263. PubMed ID: 29089944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
    Chen PL; Roh W; Reuben A; Cooper ZA; Spencer CN; Prieto PA; Miller JP; Bassett RL; Gopalakrishnan V; Wani K; De Macedo MP; Austin-Breneman JL; Jiang H; Chang Q; Reddy SM; Chen WS; Tetzlaff MT; Broaddus RJ; Davies MA; Gershenwald JE; Haydu L; Lazar AJ; Patel SP; Hwu P; Hwu WJ; Diab A; Glitza IC; Woodman SE; Vence LM; Wistuba II; Amaria RN; Kwong LN; Prieto V; Davis RE; Ma W; Overwijk WW; Sharpe AH; Hu J; Futreal PA; Blando J; Sharma P; Allison JP; Chin L; Wargo JA
    Cancer Discov; 2016 Aug; 6(8):827-37. PubMed ID: 27301722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages?
    Aryal MR; Bhatt VR; Tandra P; Krishnamurthy J; Yuan J; Greiner TC; Akhtari M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e19-23. PubMed ID: 24183500
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells.
    Ray A; Das DS; Song Y; Richardson P; Munshi NC; Chauhan D; Anderson KC
    Leukemia; 2015 Jun; 29(6):1441-4. PubMed ID: 25634684
    [No Abstract]   [Full Text] [Related]  

  • 39. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
    Wei J; Nduom EK; Kong LY; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C; Fuller GN; Gilbert MR; Overwijk W; Calin GA; Heimberger AB
    Neuro Oncol; 2016 May; 18(5):639-48. PubMed ID: 26658052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes.
    Shi L; Meng T; Zhao Z; Han J; Zhang W; Gao F; Cai J
    Gene; 2017 Dec; 636():36-41. PubMed ID: 28888577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.